Neuroendocrine cell type-specific and inducible expression of chromogranin/secretogranin genes: Crucial promoter motifs

Annals of the New York Academy of Sciences

Volumn 971, Issue , 2002, Pages 27-38

  Mahata, Sushil K ^a,b   Mahapatra, Nitish R ^a   Mahata, Manjula ^a   O'Connor, Daniel T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Catecholamines; Chromogranin A; Chromogranin B; PC12 cells; Secretogranin II

Indexed keywords

CATECHOLAMINE; CHROMOGRANIN; CHROMOGRANIN A; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINIC RECEPTOR; PROTEIN KINASE C; SECRETOGRANIN II;

ANIMAL CELL; CATECHOLAMINE RELEASE; CELL SPECIFICITY; CHROMAFFIN CELL; CONFERENCE PAPER; CYCLIC AMP RESPONSIVE ELEMENT; GC RICH SEQUENCE; GENE EXPRESSION; GENE INDUCTION; GENE STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; NEUROSECRETORY CELL; NONHUMAN; PEPTIDERGIC NERVOUS SYSTEM; PROMOTER REGION; SECRETORY VESICLE; SERUM RESPONSIVE ELEMENT;

ANIMALIA;

EID: 0037024638     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04429.x     Document Type: Conference Paper

References (60)

1. O'Connor, D.T. 1983. Chromogranin: Widespread immunoreactivity in polypeptide hormone producing tissues and in serum. Regul. Pept. 6: 263-280.
2. Winkler, H. & R. Fischer-Colbrie. 1992. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49: 497-528.
3. Huttner, W.B., H.H. Gerder & P. Rosa. 1991. The granin (chromogranin/secretogranin) family. Trends Biochem. Sci. 16: 27-30.
4. Fischer-Colbrie, R., A. Laslop & R. Kirchmair. 1995. Secretogranin II: Molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. Prog. Neurobiol. 46: 49-70.
5. Tang, K., H. Wu, S.K. Mahata, et al. 1996. Stimulus-transcription coupling in pheochromocytoma cells. Promoter region-specific activation of chromogranin A biosynthesis. J. Biol. Chem. 271: 28382-28390.
6. Tang, K., H. Wu, S.K. Mahata, et al. 1997. Stimulus coupling to transcription versus secretion in pheochromocytoma cells. Convergent and divergent signal transduction pathways and the crucial roles for route of cytosolic calcium entry and protein kinase C. J. Clin. Invest. 100: 1180-1192.
7. Tang, K., H. Wu, S.K. Mahata & D.T. O'Connor. 1998. A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells. Mol. Pharmacol. 54: 59-69.
8. Taupenot, C., S.K. Mahata, H. Wu & D.T. O'Connor. 1998. Peptidergic activation of transcription and secretion in chromaffin cells, cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP). J. Clin. Invest. 101: 863-876.
9. Mahata, S.K., M. Mahata, C.V. Livsey, et al. 1999. Neuroendocrine cell type-specific and inducible expression of the secretogranin II gene: Crucial role of cyclic adenosine monophosphate and serum response elements. Endocrinology 140: 739-749.
10. Mahapatra, N.R., M. Mahata, A. Datta, et al. 2000. Neuroendocrine cell type-specific and inducible expression of the chromogranin B gene: Crucial role of the proximal promoter. Endocrinology 141: 3668-3678.
11. Turquier, V., L. Yon, L. Grumolato, et al. 2001. Pituitary adenylate cyclase-activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells through multiple signaling pathways and increased binding of pre-existing activator protein-1-like transcription factors. Mol. Pharmacol. 60: 42-52.
12. Mahata, S.K., D.T. O'Connor, M. Mahata, et al. 1997. Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. J. Clin. Invest. 100: 1623-1633.
13. Mahata, S.K., M. Mahata, R.J. Parmer & D.T. O'Connor. 1999. Desensitization of catecholamine release: The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364) acts at the receptor to prevent nicotinic cholinergic tolerance. J. Biol. Chem. 274: 2920-2928.
14. Mahata, S.K., M. Mahata, A.R. Wakade & D.T. O'Connor. 2000. Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A344-364): Identification of amino acid residues crucial for activity. Mol. Endocrinol. 14: 1525-1535.
15. Aardal, S., K.B. Helle, S. Elsayed, et al. 1993. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J. Neuroendocrinol. 5: 405-412.
16. Tatemoto, K., S. Efendic, V. Mutt, et al. 1986. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324: 476-478.
17. Kirchmair, R., R. Hogue-Angeletti, J. Gutierrez, et al. 1993. Secretoneurin-A neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 53: 359-365.
18. Reinisch, N., R. Kirchmair, C.M. Kahler, et al. 1993. Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett. 334: 41-44.
19. Saria, A., J. Troger, R. Kirchmair, et al. 1993. Secretoneurin releases dopamine from rat striatal slices: A biological effect of a peptide derived from secretogranin II (chromogranin C). Neuroscience 54: 1-4.
20. Videen, J.S., M.S. Mezger, Y.M. Chang & D.T. O'Connor. 1992. Calcium and catecholamine interactions with adrenal chromogranins. Comparison of driving forces in binding and aggregation. J. Biol. Chem. 267: 3066-3073.
21. Kim, T., J. Tao-Cheng, L.E. Eiden & Y.P. Loh. 2001. Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis. Cell 106: 499-509.
22. Huttner, W.B. & S. Natori. 1995. Regulated secretion. Helper proteins for neuroendocrine secretion. Curr. Biol. 5: 242-245.
23. Wu, H.J., D.J. Rozansky, R.J. Parmer, et al. 1991. Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expression. J. Biol. Chem. 266: 13130-13134.
24. Mouland, A.J., S. Bevan, J.H. White & G.N. Hendy. 1994, Human chromogranin A gene. Molecular cloning, structural analysis, and neuroendocrine cell-specific expression. J. Biol. Chem. 269: 6918-6926.
25. Lugardon, K., S. Chasserot-Golaz, A.E. Kieffer, et al. 2001. Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide. J. Biol. Chem. 276: 35875-35882.
26. 2+-dependent endopeptidase and carboxypeptidase H (EC 3.4.17.10). Biochem. J. 244: 457-464.
27. Curry, W.J., C. Shaw, C.F. Johnston, et al. 1992. Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour. FEBS Lett. 301: 319-321.
28. Kirchmair, R., B. Leitner, R. Fischer-Colbrie, et al. 1995. Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues. Biochem. J. 310: 331-336.
29. Pohl, T.M., E. Phillips, K.Y. Song, et al. 1990. The organisation of the mouse chromogranin B (secretogranin I) gene. FEBS Lett. 262: 219-224.
30. Strub, J.M., P. Hubert, G. Nullans, et al. 1996. Antibacterial activity of secretolytin, a chromogranin B-derived peptide (614-626), is correlated with peptide structure. FEBS Lett. 379: 273-278.
31. Schimmel, A., O. Braunling, U. Ruther, et al. 1992. The organisation of the mouse secretogranin II gene. FEBS Lett. 314: 375-380.
32. Anouar, Y., C. Desmoucelles, L. Yon, et al. 1998. Identification of a novel secretogranin II-derived peptide (SgII(187-252)) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide. J. Clin. Endocrinol. Metab. 83: 2944-2951.
33. Wu, H., D.J. Rozansky, N.J. Webster & D.T. O'Connor. 1994. Cell type-specific gene expression in the neuroendocrine system. A neuroendocrine-specific regulatory element in the promoter of chromogranin A, a ubiquitous secretory granule core protein. J. Clin. Invest. 94: 118-129.
34. Wu, H., S.K. Mahata, M. Mahata, et al. 1995. A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A. J. Clin. Invest. 96: 568-578.
35. Nolan, E.M., T.C. Cheung, D.W. Burton & L.J. Deftos. 1995. Identification and characterization of a neuroendocrine-specific 5′-regulatory region of the human chromogranin A gene. Endocrinology 136: 5632-5638.
36. Desmoucelles, C., H. Vaudry, L.E. Eiden & Y. Anour. 1999. Synergistic action of upstream elements and a promoter-proximal CRE is required for neuroendocrine cell-specific expression and second- messenger regulation of the gene encoding the human secretory protein secretogranin II. Mol. Cell. Endocrinol. 157: 55-66.
37. Scammell, J.G., S. Reddy, D.L. Valentine, et al. 2000. Isolation and characterization of the human secretogranin II gene promoter. Brain Res. Mol. Brain Res. 75: 8-15.
38. Livett, B.G. & P.D. Marley. 1993. Noncholinergic control of adrenal catecholamine secretion. J. Anat. 183: 277-289.
39. Wakade, A.R. 1988. Noncholinergic transmitter(s) maintains secretion of catecholamines from rat adrenal medulla for several hours of continuous stimulation of splanchnic neurons. J. Neurochem. 50: 1302-1308.
40. Simon, J.P., M.F. Bader & D. Aunis. 1988. Secretion from chromaffin cells is controlled by chromogranin A-derived peptides. Proc. Natl. Acad. Sci. USA 85: 1712-1716.
41. Tschernitz, C., A. Laslop, C. Eiter, et al. 1995. Biosynthesis of large dense-core vesicles in PC12 cells: Effects of depolarization and second messengers on the mRNA levels of their constituents. Brain Res. Mol. Brain Res. 31: 131-140.
42. Eiden, L.E., A. Iacangelo, C.M. Hsu, et al. 1987. Chromogranin A synthesis and secretion in chromaffin cells. J. Neurochem. 49: 65-74.
43. Bauer, J.W., R. Kirchmair, C. Egger & R. Fischer-Colbrie. 1993. Histamine induces a gene-specific synthesis regulation of secretogranin II but not of chromogranin A and B in chromaffin cells in a calcium-dependent manner. J. Biol. Chem. 268: 1586-1589.
44. Laslop, A., T. Wohlfarter, R. Fischer-Colbrie, et al. 1989. Insulin hypoglycemia increases the levels of neuropeptide Y and calcitonin gene-related peptide, but not of chromogranins A and B, in rat chromaffin granules. Regul. Pept. 26: 191-202.
45. Thompson, M.E., W.E. Zimmer, L.B. Wear, et al. 1992. Differential regulation of chromogranin B/secretogranin I and secretogranin II by forskolin in PC12 cells. Brain Res. Mol. Brain Res. 12: 195-202.
46. Jungling, S., G. Cibelli, M. Czardybon, et al. 1994. Differential regulation of chromogranin B and synapsin I gene promoter activity by cAMP and cAMP-dependent protein kinase. Eur. J. Biochem. 226: 925-935.
47. Mahata, S.K., M. Mahata, R. Fischer-Colbrie & H. Winkler. 1993. Reserpine causes differential changes in the mRNA levels of chromogranin B, secretogranin II, carboxypeptidase H, alpha-amidating monooxygenase, the vesicular amine transporter and of synaptin/synaptophysin in rat brain. Brain Res. Mol. Brain Res. 19: 83-92.
48. Mahata, S.K., J. Marksteiner, G. Sperk, et al. 1992. Temporal lobe epilepsy of the rat: Differential expression of mRNAs of chromogranin B, secretogranin II, synaptin/synaptophysin and p65 in subfield of the hippocampus. Brain Res. Mol. Brain Res. 16: 1-12.
49. Laslop, A. & C. Tschernitz. 1992. Effects of nerve growth factor on the biosynthesis of chromogranin A and B, secretogranin II and carboxypeptidase H in rat PC12 cells. Neuroscience 49: 443-450.
50. Mahata, S.K., M. Mahata, H.J. Steiner, et al. 1992. In situ hybridization: mRNA levels of secretogranin II, neuropeptides and carboxypeptidase H in brains of salt-loaded and Brattleboro rats. Neuroscience 48: 669-680.
51. Mahata, S.K., M. Mahata, R. Fischer-Colbrie & H. Winkler. 1993. In situ hybridization: mRNA levels of secretogranin II, VGF and peptidylglycine alpha-amidating monooxygenase in brain of salt-loaded rats. Histochemistry 99: 287-293.
52. Mahata, S.K., M. Mahata, H. Hortnagl, et al. 1993. Concomitant changes of messenger ribonucleic acid levels of secretogranin II, VGF, vasopressin and oxytocin in the paraventricular nucleus of rats after adrenalectomy and during lactation. J. Neuroendocrinol. 5: 323-330.
53. Mahata, M., H. Hortnagl, S.K. Mahata, et al. 1993. Messenger RNA levels of chromogranin B, secretogranin II, and VGF in rat brain after AF64A-induced septohippocampal cholinergic lesions. J. Neurochem. 61: 1648-1656.
54. Laslop, A., S.K. Mahata, M. Wolkersdorfer, et al. 1994. Large dense-core vesicles in rat adrenal after reserpine: Levels of mRNAs of soluble and membrane-bound constituents in chromaffin and ganglion cells indicate a biosynthesis of vesicles with higher secretory quanta. J. Neurochem. 62: 2448-2456.
55. Fischer-Colbrie, R., J. Gutierrez, C.M. Hsu, et al. 1990. Sequence analysis, tissue distribution and regulation by cell depolarization, and second messengers of bovine secretogranin II (chromogranin C) mRNA. J. Biol. Chem. 265: 9208-9213.
56. Wolkersdorfer, M., C. Egger, A. Laslop & R. Fischer-Colbrie. 1996. Nicotine and prostaglandin E induce secretogranin II levels in bovine chromaffin cells. Brain Res. Mol. Brain Res. 38: 260-266.
57. Scammell, J.G., C. Sumners, M.A. Reutter, et al. 1995. Regulation of secretogranin II mRNA in rat neuronal cultures. Brain Res. Mol. Brain Res. 33: 326-332.
58. Chrivia, J.C., R.P. Kwok, N, Lamb, et al. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365: 855-859.
59. Kurokawa, R., D. Kalafus, M.H. Ogliastro, et al. 1998. Differential use of CREB binding protein-coactivator complexes. Science 279: 700-703.
60. Korzus, E., J. Torchja, D.W. Rose, et al. 1998. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279: 703-707.